✍ Scribed by E. J. Calderón; C. Rey; F. J. Medrano; J. Sánchez-Román; V. Soriano; Y. Torres; M. Ruiz; E. Lissen; M. Leal
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The retroviruses human immunodeficiency virus (HIV)‐1/2 and human T‐cell leukemia virus (HTLV)‐I/II share modes of transmission, suggesting that efforts to monitor the current HIV‐1 epidemic in Switzerland should be complemented by assessment of HTLV‐I/II prevalence. This study presents
The prevalence of human T-cell leukaemia virus-I and -II infection was studied in a cohort of 346 intravenous and nonintravenous drug users in Amsterdam. Three participants (0.86%) had antibodies to HTLV-I by two commercially available HTLV-I enzyme immunoassays (EIA). Infection in these three subje
The human T-lymphotropic virus type II (HTLV-II) has recently been associated with the genesis of some subacute neurological syndromes and, rarely, with atypical T-lymphoid malignancies. The virus is endemic in some Amerindian and African tribes, and among intravenous drug users (IDUs) in North Amer